Latest Insider Transactions at Hca Healthcare, Inc. (HCA)
This section provides a real-time view of insider transactions for Hca Healthcare, Inc. (HCA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HCA Healthcare, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HCA Healthcare, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 18
2021
|
Joseph A Sowell Iii SVP; Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,160
-20.36%
|
$549,840
$174.61 P/Share
|
|
Feb 18
2021
|
Joseph A Sowell Iii SVP; Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,147
+39.54%
|
-
|
|
Feb 18
2021
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
SELL
Payment of exercise price or tax liability
|
Direct |
3,192
-14.18%
|
$555,408
$174.61 P/Share
|
|
Feb 18
2021
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
BUY
Grant, award, or other acquisition
|
Direct |
8,111
+26.49%
|
-
|
|
Feb 18
2021
|
Robert A Waterman SVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
5,583
-1.56%
|
$971,442
$174.61 P/Share
|
|
Feb 18
2021
|
Robert A Waterman SVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
14,186
+3.81%
|
-
|
|
Feb 18
2021
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,575
-20.87%
|
$448,050
$174.61 P/Share
|
|
Feb 18
2021
|
Kathleen M Whalen SVP & Chief Ethics Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,322
+29.68%
|
-
|
|
Feb 18
2021
|
Christopher F. Wyatt SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
2,360
-6.99%
|
$410,640
$174.61 P/Share
|
|
Feb 18
2021
|
Christopher F. Wyatt SVP & Controller |
BUY
Grant, award, or other acquisition
|
Direct |
8,111
+19.38%
|
-
|
|
Feb 16
2021
|
Jennifer Berres SVP & Chief Human Res. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,633
-48.62%
|
$1,328,142
$174.0 P/Share
|
|
Feb 16
2021
|
Jennifer Berres SVP & Chief Human Res. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,325
+36.92%
|
$830,850
$58.47 P/Share
|
|
Feb 12
2021
|
Charles J Hall Group President |
SELL
Bona fide gift
|
Direct |
5,736
-2.66%
|
-
|
|
Feb 08
2021
|
Jon M Foster EVP and COO |
SELL
Open market or private sale
|
Direct |
6,171
-100.0%
|
$1,086,096
$176.44 P/Share
|
|
Feb 08
2021
|
Christopher F. Wyatt SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
4,308
-14.39%
|
$766,824
$178.94 P/Share
|
|
Feb 08
2021
|
Christopher F. Wyatt SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+21.09%
|
$544,000
$68.96 P/Share
|
|
Feb 05
2021
|
Michael S. Cuffe EVP and Chief Clinical Officer |
SELL
Open market or private sale
|
Direct |
13,718
-32.68%
|
$2,414,368
$176.22 P/Share
|
|
Feb 05
2021
|
A Bruce Moore Jr Group President - Service Line |
SELL
Open market or private sale
|
Direct |
10,000
-8.64%
|
$1,790,000
$179.93 P/Share
|
|
Feb 05
2021
|
Robert A Waterman SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
62,936
-15.46%
|
$11,139,672
$177.38 P/Share
|
|
Feb 04
2021
|
Jon M Foster EVP and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,829
-48.58%
|
$1,043,391
$179.3 P/Share
|
|
Feb 04
2021
|
Jon M Foster EVP and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+50.0%
|
$564,000
$47.97 P/Share
|
|
Feb 04
2021
|
Charles J Hall Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
10,507
-4.85%
|
$1,880,753
$179.3 P/Share
|
|
Feb 04
2021
|
Charles J Hall Group President |
BUY
Exercise of conversion of derivative security
|
Direct |
16,028
+3.63%
|
$1,458,548
$91.56 P/Share
|
|
Feb 04
2021
|
J William Morrow SVP - Finance and Treasurer |
BUY
Bona fide gift
|
Indirect |
227
+10.23%
|
-
|
|
Feb 04
2021
|
J William Morrow SVP - Finance and Treasurer |
SELL
Bona fide gift
|
Direct |
227
-17.72%
|
-
|
|
Feb 04
2021
|
P. Martin Paslick SVP and CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,025
-47.74%
|
$899,475
$179.3 P/Share
|
|
Feb 04
2021
|
P. Martin Paslick SVP and CIO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,525
+50.0%
|
$494,675
$47.97 P/Share
|
|
Feb 04
2021
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
37,721
-41.09%
|
$6,752,059
$179.3 P/Share
|
|
Feb 04
2021
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
BUY
Exercise of conversion of derivative security
|
Direct |
69,375
+43.04%
|
$3,260,625
$47.97 P/Share
|
|
Feb 04
2021
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
SELL
Payment of exercise price or tax liability
|
Direct |
6,733
-31.86%
|
$1,205,207
$179.3 P/Share
|
|
Feb 04
2021
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
BUY
Exercise of conversion of derivative security
|
Direct |
9,150
+30.22%
|
$924,150
$101.16 P/Share
|
|
Feb 04
2021
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
SELL
Open market or private sale
|
Direct |
3,516
-11.81%
|
$618,816
$176.0 P/Share
|
|
Feb 04
2021
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
653
-13.99%
|
$116,887
$179.3 P/Share
|
|
Feb 04
2021
|
Kathleen M Whalen SVP & Chief Ethics Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,400
+23.07%
|
$65,800
$47.97 P/Share
|
|
Feb 04
2021
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Bona fide gift
|
Direct |
415
-11.26%
|
-
|
|
Feb 04
2021
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Open market or private sale
|
Direct |
280
-7.06%
|
$49,560
$177.11 P/Share
|
|
Feb 04
2021
|
Wayne Joseph Riley Director |
SELL
Open market or private sale
|
Direct |
1,650
-11.69%
|
$288,750
$175.0 P/Share
|
|
Feb 03
2021
|
Michael S. Cuffe EVP and Chief Clinical Officer |
SELL
Open market or private sale
|
Direct |
7,574
-15.29%
|
$1,295,154
$171.17 P/Share
|
|
Feb 03
2021
|
Michael S. Cuffe EVP and Chief Clinical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
23,772
-32.42%
|
$4,112,556
$173.12 P/Share
|
|
Feb 03
2021
|
Michael S. Cuffe EVP and Chief Clinical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
37,490
+22.75%
|
$2,811,750
$75.77 P/Share
|
|
Feb 03
2021
|
A Bruce Moore Jr Group President - Service Line |
SELL
Payment of exercise price or tax liability
|
Direct |
22,848
-16.48%
|
$3,952,704
$173.12 P/Share
|
|
Feb 03
2021
|
A Bruce Moore Jr Group President - Service Line |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+26.51%
|
$1,100,000
$22.95 P/Share
|
|
Feb 03
2021
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
SELL
Open market or private sale
|
Direct |
1,550
-9.09%
|
$263,500
$170.94 P/Share
|
|
Feb 03
2021
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
SELL
Payment of exercise price or tax liability
|
Direct |
8,375
-32.95%
|
$1,448,875
$173.12 P/Share
|
|
Feb 03
2021
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
BUY
Exercise of conversion of derivative security
|
Direct |
13,758
+17.85%
|
$1,045,608
$76.22 P/Share
|
|
Feb 03
2021
|
Robert A Waterman SVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
140,711
-25.69%
|
$24,343,003
$173.12 P/Share
|
|
Feb 03
2021
|
Robert A Waterman SVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
277,500
+16.66%
|
$9,990,000
$36.03 P/Share
|
|
Feb 03
2021
|
Wayne Joseph Riley Director |
SELL
Open market or private sale
|
Direct |
1,650
-10.46%
|
$273,900
$166.19 P/Share
|
|
Nov 24
2020
|
Deborah M Reiner SVP - Mktg. & Communications |
SELL
Open market or private sale
|
Direct |
1,266
-18.76%
|
$196,230
$155.0 P/Share
|
|
Nov 17
2020
|
Deborah M Reiner SVP - Mktg. & Communications |
SELL
Payment of exercise price or tax liability
|
Direct |
5,771
-46.09%
|
$882,963
$153.03 P/Share
|